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Expression cloning and functional characterization of the kidney
cortex high-affinity proton-coupled peptide transporter
Abstract
The presence of a proton-coupled electrogenic high-affinity peptide transporter in the apical membrane
of tubular cells has been demonstrated by microperfusion studies and by use of brush border membrane
vesicles. The transporter mediates tubular uptake of filtered di- and tripeptides and aminocephalosporin
antibiotics. We have used expression cloning in Xenopus laevis oocytes for identification and
characterization of the renal high-affinity peptide transporter. Injection of poly(A)+ RNA isolated from
rabbit kidney cortex into oocytes resulted in expression of a pH-dependent transport activity for the
aminocephalosporin antibiotic cefadroxil. After size fractionation of poly(A)+ RNA the transport
activity was identified in the 3.0- to 5.0-kb fractions, which were used for construction of a cDNA
library. The library was screened for expression of cefadroxil transport after injection of complementary
RNA synthesized in vitro from different pools of clones. A single clone (rPepT2) was isolated that
stimulated cefadroxil uptake into oocytes approximately 70-fold at a pH of 6.0. Kinetic analysis of
cefadroxil uptake expressed by the transporter's complementary RNA showed a single saturable
high-affinity transport system shared by dipeptides, tripeptides, and selected amino-beta-lactam
antibiotics. Electrophysiological studies established that the transport activity is electrogenic and
affected by membrane potential. Sequencing of the cDNA predicts a protein of 729 amino acids with 12
membrane-spanning domains. Although there is a significant amino acid sequence identity (47%) to the
recently cloned peptide transporters from rabbit and human small intestine, the renal transporter shows
distinct structural and functional differences.
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ABSTRACT The presence of a proton-coupled electro-
genic high-affinity peptide transporter in the apical mem-
brane of tubular cells has been demonstrated by microperfu-
sion studies and by use of brush border membrane vesicles.
The transporter mediates tubular uptake of filtered di- and
tripeptides and aminocephalosporin antibiotics. We have used
expression cloning in Xenopus laevis oocytes for identification
and characterization of the renal high-affinity peptide trans-
porter. Injection of poly(A)+ RNA isolated from rabbit kidney
cortex into oocytes resulted in expression of a pH-dependent
transport activity for the aminocephalosporin antibiotic ce-
fadroxil. After size fractionation of poly(A)+ RNA the trans-
port activity was identified in the 3.0- to 5.0-kb fractions,
which were used for construction of a cDNA library. The
library was screened for expression of cefadroxil transport
after injection of complementary RNA synthesized in vitro
from different pools of clones. A single clone (rPepT2) was
isolated that stimulated cefadroxil uptake into oocytes "70-
fold at a pH of 6.0. Kinetic analysis of cefadroxil uptake
expressed by the transporter's complementary RNA showed a
single saturable high-affinity transport system shared by
dipeptides, tripeptides, and selected amino-f3-lactam antibi-
otics. Electrophysiological studies established that the trans-
port activity is electrogenic and affected by membrane poten-
tial. Sequencing of the cDNA predicts a protein of 729 amino
acids with 12 membrane-spanning domains. Although there is
a significant amino acid sequence identity (47%) to the
recently cloned peptide transporters from rabbit and human
small intestine, the renal transporter shows distinct struc-
tural and functional differences.
One of the functions of kidney tubular cell is the reabsorption
of di- and tripeptides filtered or generated by enzymatic
hydrolysis of oligopeptides after glomerular filtration. The
presence of a high-affinity peptide transporter in the apical
membrane of tubular cells was demonstrated by microperfu-
sion studies (1) and in isolated brush border membrane vesicles
(BBMV) (2-6). The transporter was found to operate in an
electrogenic mode by coupling of substrate influx to an
inwardly directed proton gradient. Besides di- and tripeptides,
a variety of peptide mimetics with a peptide backbone were
found to interact with the transporter's substrate-binding site
(7-12).
The following observations made it possible to clone a
cDNA from rabbit kidney cortex that codes for a protein
related to peptide and aminocephalosporin transport: (i) In-
jection of poly(A)+ RNA isolated from rabbit kidney cortex
into Xenopus laevis oocytes resulted in the expression of
saturable sodium-independent transport activity for the ami-
nocephalosporin [3H]cefadroxil. (ii) The mRNA coding for the
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement" in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
expressed transport activity was found in the 3.0- to 5.0-kb
fractions. From a corresponding cDNA library we isolated a
cDNA clone$ that, after in vitro transcription and injection into
X laevis oocytes, induced a pH- and voltage-dependent trans-
port system for aminocephalosporins and dipeptides.1I
MATERIALS AND METHODS
Materials. Custom-synthesized [3H]cefadroxil (39 Ci/
mmol; 1 Ci=37 GBq) was obtained from Amersham. The
amino acids L-[3-3H]alanine (76.9 Ci/mmol), L-[4-3H(N)]pro-
line (19.9 Ci/mmol), and L-[2,3-3H]glutamate (19.2 Ci/mmol)
and 3-O-[3H]methyl-D-glucose (86.7 Ci/mmol) were obtained
from DuPont/NEN. ,B-Lactams, peptides, and carbonylcya-
nide p-trifluoromethoxyphenylhydrazone (CFCCP) were pur-
chased from Sigma.
X. laevis Oocytes and Transport Assay. The techniques and
methods concerning preparation and handling of oocytes have
been described in detail (14, 15). Oocytes were injected with
50 nl of water (controls) or 50 nl of RNA solutions containing
either poly(A)+ RNA or the transporter complementary RNA
(cRNA), and 3 days later uptake of [3H]cefadroxil and selected
3H-labeled compounds was measured for 30 min in a buffer
composed of 100 mM NaCl (or choline chloride), 3 mM KCl,
1 mM CaCl2, 1 mM MgCl2, 10 mM N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid (Hepes)/Tris for pH values 2
6.5 or 10 mM 2-(N-morpholino)ethanesulfonic acid (Mes)/
Tris for pH values c 6.5. Uptake rates of cefadroxil into
water-injected control oocytes were always subtracted from
uptake rates in oocytes expressing rPepT2.
Construction and Screening of cDNA Libraries. Since en-
hanced transport activity for cefadroxil was identified in the
3.0- to 5.0-kb fractions of the poly(A)+ RNA, an expression
library was constructed with the corresponding cDNAs by the
Super-Script plasmid system II (pSPORT1 vector; GIBCO/
BRL). The library contained -1.7 X 105 colonies, of which
40,000 have been screened by a sib-selection procedure (15);
initial pools for screening contained "2000 colonies. Plasmid
DNA was isolated by alkaline lysis. Plasmids were linearized
with Not I and used for in vitro synthesis of cRNA as described
previously (14). The cRNA was dissolved in water, and 50 nl
of water (control) or 50 nl ofcRNA solutions was injected into
individual oocytes. Uptake of [3H]cefadroxil into oocytes was
generally measured 3 days after injection of the cRNA.
Abbreviations: BBMV, brush border membrane vesicles; CFCCP,
carbonylcyanide p-trifluoromethoxyphenylhydrazone; cRNA, com-
plementary RNA; ACE, angiotensin-converting enzyme.
*To whom reprint requests should be addressed.
IThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. U32507).
IlParts of this work were presented at the Experimental Biology
Meeting, April 9-13, 1995, Atlanta, and published in abstract form
(13).
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Electrophysiology. A conventional two-electrode voltage
clamp technique was applied to characterize responses in
current (I) and transmembrane potential (Vm) to substrate
addition in oocytes injected with 5 ng of transporter cRNA as
described (16, 17). Steady-state current-voltage (I-V) rela-
tionships were measured in the absence and the presence of 1
mM cefadroxil at pH values of 7.4, 6.5, and 5.5. Membrane
potential in oocytes was held at -60 mV and stepped sym-
metrically to test potentials from -150 mV to +50 mV by
500-ms rectangular voltage pulses, and current recordings
were obtained during the last 100 ms.
Isolation of Poly(A)+ RNA and Northern Blot Analysis.
Total RNA from rabbit tissues was isolated by the acid
guanidinium thiocyanate/phenol/chloroform extraction pro-
cedure, and polyadenylylated mRNA was purified from total
RNA preparations by using Dynabeads oligo(dT)25 (Dynal,
Oslo). Then 3.5 ,ug of poly(A)+ RNA was separated electro-
phoretically on a formaldehyde-containing 1.5% agarose gel
and blotted onto a nylon membrane. The rPepT2 mRNA was
hybridized with an antisense RNA probe labeled with digoxi-
genin-UTP (Boehringer Mannheim). The hybridization probe
was generated from a 1.24-kb fragment of the 5' end of the
rPepT2 cDNA. All procedures for hybridization, posthybrid-
ization washing, and the immunological detection of the
hybrids were performed according to the protocols supplied by
the manufacturers (Boehringer Mannheim information no.
1664 204). For hybridization of subtypes of the rPepT2 mes-
sage in other tissues the recommended hybridization temper-
ature was reduced from 68°C to 63°C.
In Vitro Translation. Capped cRNA from the in vitro
transcription was translated in the presence of [35S]methionine
(ICN) by using a rabbit reticulocyte lysate system (Serva), and
for translational processing canine pancreatic microsomal
membranes (Serva) were added. Proteins were analyzed by
SDS/10% PAGE.
DNA Sequencing. The rPepT2 cDNA was digested with
BamHI and EcoRI and the fragments were subcloned in a
pSportl or a pBluescript KS vector. Sequencing of both strands
was carried out by the chain-termination method using a T7
polymerase sequencing kit (United States Biochemical). Syn-
thetic oligonucleotides were used as primers (Eurogene, Se-
raing, Belgium) to proceed throughout the entire sequence as
described previously (15).
Calculations. All calculations were performed by using
INPLOT (GraphPad, San Diego). The experiments were gen-
erally carried out in triplicate with at least three batches of
oocytes, and results are presented as the mean ± SEM.
RESULTS AND DISCUSSION
A single clone (rPepT2) was isolated by screening for expres-
sion of pH gradient-dependent uptake of cefadroxil inX laevis
oocytes. Injection of various amounts (0.1-25 ng) of the cRNA
synthesized from this clone increased uptake of cefadroxil up
to 70-fold over background at 0.1 ,uM cefadroxil (Fig. 1). There
was no increased uptake of 25 ,uM [3H]alanine, [3H]proline,
[3H]glutamate, or 3-0-[3H]methyl glucose in oocytes injected
with 5 ng of the transporter cRNA compared with water-
injected controls (data not shown). When influx of cefadroxil
was determined as a function of incubation pH, a distinct pH
profile was obtained. Uptake increased severalfold when the
pH was decreased from 8.0 to 6.0 or 5.5 (Fig. 2). In contrast,
cefadroxil uptake in water-injected control oocytes was hardly
detectable and did not respond significantly to alterations in
external pH. The cation specificity of the induced transport
activity in cRNA-injected oocytes was determined both at low
pH (pH 6.0) and high pH (pH 7.4, not shown) by replacing
NaCl with choline chloride. At neither pH did the replacement
of Na+ reduce cefadroxil influx (Fig. 2), indicating that HI
rather than Na+ may serve as the cotransported ion species.
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FIG. 1. Uptake of [3H]cefadroxil into X laevis oocytes expressing
rPepT2 as a function of the cRNA amount injected (A) and incubation
time (B). (A) Oocytes were injected with 50 nl of a solution containing
0.1-25 ng of the peptide transporter cRNA, and 3 days after injection
transport was measured for 30 min at pH 6.0 in the presence of 100 mM
NaCl and 0.1 ,uM [3H]cefadroxil (4 ,tCi/ml). (B) Oocytes were injected
with 50 nl of water (a) or 5 ng of rPepT2 cRNA (0), and 3 days after
injection uptake of 0.1 ,uM [3H]cefadroxil (4 ,uCi/ml) was measured
for various time intervals at pH 6.0 and in the presence of 100 mM
NaCl. Data are shown as means + SEM for 5-8 oocytes per condition
and are representative for at least three similar experiments.
Cefadroxil influx into oocytes expressing rPepT2 displayed
saturation kinetics as a function of substrate concentration at
external pH values of 8.0 to 6.0 (Fig. 3). In agreement with
previous studies in BBMV (1, 8, 10), the transporter shows a
high affinity for cefadroxil (<50 ,tM) at all pH values tested.
Substrate affinity ranged from 24 to 41 ,tM and appeared to
be unaffected by external pH, whereas Vmax was strongly
dependent on the transmembrane pH gradient imposed (Fig.
3). Maximal transport rates could be increased almost 4-fold
by reducing pH from 8.0 to 6.0. Similarly, a low external pH has
been shown to increase the Vmax of uptake of dipeptides and
13-lactam antibiotics into kidney BBMV without affecting
substrate affinity (6, 10).
To further characterize the induced transport activity with
respect to the driving force, we determined the voltage- and
pH gradient-dependence of cefadroxil uptake. Membrane
potential was measured by conventional two-electrode voltage
clamp techniques as described (16, 17). When oocytes express-
ing rPepT2 were preincubated with low-Na+ (1 mM)/high-K+
(102 mM) buffers at pH 6.0, steady-state membrane potential
was reduced from -45 ± 3 mV (control: 100 mM Na+/3 mM
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FIG. 2. Uptake of [3H]cefadroxil into X laevis oocytes expressing
rPepT2 as a function of medium pH. Oocytes were injected with 50 nl
of water (-) or 5 ng of rPepT2 RNA in 50 nl of water (0), and 3 days
after injection transport was measured at pH values of 8.0 to 5.0 in the
presence of 100 mM NaCl and 25 ,uM [3H]cefadroxil (5 jiCi/ml).
(Inset) Uptake of cefadroxil after replacement of 100 mM NaCl in the
incubation medium with 100 mM choline chloride at pH 6.0. Data are
shown as means ± SEM for 5-8 oocytes per condition and are
representative for at least three similar experiments.
Physiology: Boll et al.
Proc. Natl. Acad. Sci. USA 93 (1996)
~30 30-
0
3S 2
a 25 pH 0 20
Q 20 6.:pH 6.5 10
E 15 pH 7.4 VKm3 versus pH0
El 6 7 8
o. pH 8.0 Medium pH
-
5 pH 6.0: K,25.8 ±6.3itMco 0- pH 6.5: Km 23.8 ± 7.4 p.M
0 .... 6 .... 6.... 0 pH 7.4: Km, 32.5 ± 4.8 p.M0 100 200 300 400 500 pH 8.0: Km 40.9 ± 8.2 ,uM
Cefadroxil, ,uM
FIG. 3. Uptake of [3H]cefadroxil into X laevis oocytes expressing
rPepT2 as a function of substrate concentration and incubation pH.
Oocytes were injected with 50 nl of water or 5 ng of rPepT2 cRNA, and
transport was measured at pH values ranging between 8.0 and 6.0 in
the presence of 100 mM choline chloride and increasing concentra-
tions of cefadroxil (0.025-500 ,uM). The curves were fitted to a
Michaelis-Menten equation by nonlinear regression analysis and
apparent Km values were derived by the least-squares method. Data
represent the means + SEM for 8-15 oocytes per condition and three
oocyte batches.
K+) to -2 + 3 mV. Cefadroxil (1 ,uM) uptake into these
oocytes was consequently reduced from 0.41 + 0.08
pmolhmin-I in control oocytes to 0.10 + 0.05 pmolbmin-I at
low membrane potentials. When membrane potential and
proton gradient were collapsed (resulting membrane potential:
2 + 3 mV) by use of the protonophore CFCCP (25 ,M),
cefadroxil uptake into oocytes was abolished (0.05 ± 0.05
pmol.min-1). These observations, together with the finding
that transport velocity but not Km is affected by low extracel-
lular pH, strongly suggest a cefadroxil/H+ symport that is
electrogenic and affected by the transmembrane potential.
The rheogenic character of cefadroxil/H+ cotransport was
finally demonstrated directly by use of the two-electrode
voltage clamp technique. When membrane potential of oo-
cytes was clamped to - 60 mV, the addition of 1 mM cefadroxil
or glycyl-L-aspartate to a Na+-free perfusion medium (pH 6.0)
caused significant inward currents (Fig. 4A) that were reversed
by perfusion with a substrate-free medium. Steady-state I-V
relationships shown in Fig. 4B demonstrate that uptake of
A buffer pH 6.0 buffer pH 6.0
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FIG. 5. Substrate-dependent currents as a function of pH. Record-
ings of inward currents by two-electrode voltage clamp in oocytes
expressing rPepT2. Experiments were performed at pH 7.4, 6.5, and
5.5 in the absence or the presence of 1 mM cefadroxil (0) or the
dipeptide Gly-Asp (0). The transport rate is expressed as percent
increase in current at pH 6.5 and 5.5 compared to the absence of a pH
gradient (pH 7.4). Data are presented as means + SEM for repeated
measurements in 5-8 oocytes per condition. The data were submitted
to linear regression analysis, and the P value of -s0.005 indicates a
significant dependence of transport activity on external pH.
cefadroxil mediated by rPepT2 is significantly (P e 0.001)
affected by the membrane potential. When the substrate-
induced currents at different pH values (holding potential,
-60 mV) were plotted against the medium pH a linear
relationship was obtained (Fig. 5). As in [3H]cefadroxil influx
into oocytes (Fig. 3), the transport rate increased 3-fold when
the external pH was decreased from 7.4 to 5.5. Since the net
charge of the substrate does not change significantly in the pH
range applied (18), the relationship clearly indicates that the
substrate-induced proton influx generates the currents ob-
tained. From the studies described above we conclude that the
expressed transport activity resembles an electrogenic sub-
strate/H+ cotransport system that is significantly affected by
membrane potential.
Since studies in kidney BBMV established that the trans-
porter has a broad substrate specificity (7-9), we determined
the selectivity of interaction of peptides, ,B-lactam antibiot-
ics, and aminopeptidase inhibitors with the substrate-binding
site by inhibition studies. pH gradient-dependent cefadroxil
uptake (25 ,uM) was measured in the absence or the presence
of 5 mM inhibitor. As shown in Fig. 6A, by use of a series of
125-;Vm, mV
FIG. 4. Recordings of current and current-voltage relationships in
oocytes expressing the rabbit renal peptide transporter rPepT2. (A)
Recordings of inward currents in oocytes 3 days after injection of 50
nl (5 ng per oocyte) of peptide transporter cRNA in the absence and
the presence of 1 mM cefadroxil or the dipeptide glycyl-L-aspartate at
pH 6.0 in the presence of 100 mM NaCl. Control oocytes (water
injected) did not show any response in current to the addition of
substrates. (B) Steady-state I-V relationships of proton-coupled ce-
fadroxil (0) and glycyl-L-aspartate (0) cotransport were recorded by
two-electrode voltage clamp. Oocytes were perfused with pH 6.0
buffer (100 mM NaCl) and membrane potential was held at -60 mV.
Thereafter membrane potential was stepped symmetrically to the test
potential shown and substrate-dependent currents were obtained as
the difference measured in the absence and the presence of 1 mM
cefadroxil and Gly-Asp. Data are presented as means ± SEM for 5-9
individual oocytes per condition.
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FIG. 6. Specificity of substrate interaction with cefadroxil uptake
into X. laevis oocytes expressing rPepT2. Cefadroxil uptake into
oocytes was measured for 10 min of incubation at pH 6.0 in the absence
or the presence of selected alanyl peptides (A) and peptide mimetics
(B) at 5 mM. Data are expressed as percent of residual cefadroxil
uptake compared with controls in the absence of inhibitors. Results
are shown as means + SEM for 6-10 oocytes per condition. ***,
Significantly different (P ' 0.001) from control values (Student's t
test).
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alanyl peptides we observed that only di- and tripeptides but
not peptides with more than three amino acid residues
interact with the substrate-binding site of the transporter.
The stereospecificity of interaction was determined by pep-
tides containing either L or D isomers of alanine in different
positions (Fig. 6A). Incorporation of D-alanine into the
N-terminal position maintained an inhibitory potency of the
peptide, whereas peptides with D-alanine in the C-terminal
position or in both positions failed to inhibit cefadroxil
uptake. Of the various ,3-lactam antibiotics tested, only the
cephalosporins carrying a free a-amino group (loracarbef,
cefaclor, and cephalexin) reduced cefadroxil influx (Fig. 6B).
This is consistent with previous observations in kidney
BBMV (7, 8, 10). From a variety of other compounds
suggested to serve as substrates for the peptide transporters
in epithelial cells, we chose to investigate whether angioten-
sin-converting enzyme (ACE) inhibitors and aminopepti-
dase inhibitors such as arphamenin A and bestatin inhibited
cefadroxil transport mediated by rPepT2. Whereas 5 mM
bestatin or arphamenin A significantly reduced cefadroxil
uptake by 55% 4% and 62% + 7% (data not shown), no
inhibition was seen with any of the ACE inhibitors tested
(captopril and enalapril) (Fig. 6B).
In summary, it appears that only di- and tripeptides, amin-
ocephalosporins, and selected aminopeptidase inhibitors in-
teract with the substrate-binding site of the transporter. In
contrast to the intestinal peptide/H+ symporter PepTi (17),
ACE inhibitors and 3-lactam antibiotics without an a-amino
group appear not to be transported by the renal carrier protein.
On the basis of functional criteria, including the driving force,
kinetics of transport, and substrate specificity and affinity,
rPepT2 shows some similarities with PepTI but also distinctly
different features, including a different pH dependence (under
identical experimental conditions, including the substrate), a
40 times higher substrate affinity, and a different substrate
specificity. The observed differences in structure and function
of the intestinal peptide transporter PepTI and the renal clone
rPepT2 are summarized in Table 1.
Tissue-specific expression of the mRNA corresponding to
rPepT2 was examined by Northern blot analysis (Fig. 7). In the
rabbit, a mRNA species of 4.8 kb from kidney cortex hybrid-
ized with the 1.24-kb RNA probe. Signals of similar or identical
size were obtained also in rabbit brain, lung, liver, and heart at
both low and high stringencies (Fig. 7). Although peptide
transporters with functions like those of rPepT2 have not been
described yet in any other tissue but kidney and intestine,
Northern analysis suggests that similar transporters may be
expressed in other tissues, where they could contribute to the
removal of short-chain peptides and peptide-derived drugs
circulating in the blood.
The cDNA insert of our clone was completely sequenced on
both strands. It is 4265 bp long, and the deduced amino acid
sequence (Fig. 8) from the open reading frame of the nucle-
otide sequence indicated that the gene product is a protein of
729 amino acids. Hydropathy analysis, performed as described
previously (14, 15), predicted 12 membrane-spanning domains
with a large extracellular loop between transmembrane do-
mains 9 and 10. Besides five putative extracellular N-
glycosylation sites, four intracellular consensus regions con-
taining protein kinase C motifs have been identified. In
comparisons with other members of the POT family of proton-
dependent oligopeptide transporters (18) or the major facili-
tator superfamily (19) by using the BLAST program, the pre-
dicted rPepT2 amino acid sequence shows a high identity
(47%) and similarity (67%) only with the intestinal peptide
transporter PepTl recently cloned from the rabbit small
intestine (17, 20). However, the significant identity is predom-
inantly found in the membrane-spanning domains, whereas the
large extracellular loop, which contains 210 amino acid resi-
dues, shows only a 21% sequence match. Comparisons with
Table 1. Comparison of structural and functional features of the
cloned peptide transporters from rabbit small intestine and
kidney cortex
Feature rPepT2 PepTl
Substrate specificity
a-Amino group required* Yes No
ACE inhibitors transported* No Yes
Substrate affinity
Apparent Km (cefadroxil)*, AM c50 21000
pH optimum <6.0 6.5
Molecular mass of in vitro
translation product, kDa
Unglycosylated 83 60
Core-glycosylated 107 71
Identity at the protein level, %
Overall 47
Large extracellular loop 21
Transmembrane domains 61
*Determined under identical experimental conditions in oocytes
expressing either rPepT2 or PepTl.
nonmammalian POT family members like the nitrate trans-
porter CHL1 from Arabidopsis thaliana (21) and the peptide
permease PTR2 from Saccharomyces cerevisiae (22) reveal
much lower sequence similarities.
In vitro translation of rPepT2 cRNA using a rabbit reticu-
locyte lysate in the absence and the presence of canine
pancreatic microsomes yielded translation products with
apparent molecular mass of 83 and 107 kDa, respectively
(Fig. 7). The multiple N-glycosylation sites with core glyco-
sylation therefore appear to account for almost 24 kDa of the
overall molecular mass of the rPepT2 gene product. We
recently reported the photolabeling of a 105-kDa protein in
BBMV of rat kidney cortex by using [3H]cefadroxil as a
photoprobe (23). Incorporation of the photolabel into the
105-kDa membrane protein was inhibited by (i) competing
substrates, (ii) a collapse of the protonmotive force, and (iii)
A
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FIG. 7. Distribution of rPepT2-related mRNAs in rabbit tissues
analyzed by Northern blotting (A) and in vitro translation of the
rPepT2 cRNA (B). (A) Samples (3.5 ,tg) of poly(A) + RNA from rabbit
tissues were separated by agarose gel electrophoresis, blotted, and
hybridized with a 1.24-kb rPepT2 antisense probe. The mRNA was
extracted from whole organs (liver, lung, brain, heart muscle), mucosal
scrapings (small and large intestine), or renal cortex slices. Size
standards are indicated. (B) In vitro translation of rPepT2 cRNA. For
each experiment 200 ng of cRNA was used and the translation
products were analyzed directly by SDS/10% PAGE. In the presence
of microsomes (+) the major translation product is shifted to 107 kDa,
indicating substantial core glycosylation.
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ccggaagccagcc 13
atgaatcccttccagcaaaatqagtccaagqaaactcttttttcacct4 ctccactqaa 73M N P F Q Q NE S K ET L F S P V S TE 20
§agacaccacctcgact ctccagccc9gcaaagaagacacctccgaaaatCtgtggctcc 133ET P P R L S SPAR K K T P P K I C S 40
aactatccactgagcattqccttcattqtggtgaatqaattctgcqagcgtttttcctat 193
N Y P L S I A FIV V N E F C E R F S Y 60
tatqgcatgaaaRct4tgcttaccctgtatttcctgtatttcctgcactggaatqagqac 253Y M K L T L Y F L Y F L H W N 80
acctccacatctrtctaccatqccttcagcagcctctgctatttcactcccatcctggga 313T S T SVY H A F S S L C Y F T P I L G 100
caqccatt ct actcatggctg ggaaattcaagacaatcatctatctctccttgqtg 373
A AT S W LG K F K T: I I Y L S L Vt 120
aat4tgct tggccat4tga tcaagtccttgsagcqcaFtttccaIatactc-gggqggaKaatg 433
qtacacaca4tcctatcacttqtcggcctatgtctaattqa catgqaggTcG gagqgcatc 4693
aaaccctgcqtgqcaqcttttqgtqgaqaccagtttqaaqaaaaacatgCtqaggaaCgg 553
K P C VAAF G Q F EE K H AE R 180
actagatacttctctqgcttctacctcqccatcaatgcagggagcttgatttCtacattt 613T R Y F S F Y L A_I N G S L I S T F 200
atcacacccatgctaagaggagatqtgcagtgttttggggaagactgttatqcattggct 673L T P M L R GD Q C F EL CY A L . 220
t ttga4ttccaggat tgctcatg taatagcact tt ttqtgtt tRca3atg[qgaagcaaa 733F G V P G L L M V I A L V V F A M G S K 240
atgtacaaaaaaccacc tccttaaggaaacatagtgqctcaa4tt4tcaaatgcat ctgg 793M Y K K P P P E N I Q K C I W 260
tttgctatttccaaccgcttcaagaaccgttctgaggacattccaaagcgacagcactgg 853
FA I S N R F K N R SEDI P K R Q H W 280
ttgqactgg caRccqagaaataccCaaagcagctCattatggat4tgaagaCactgacc 913LD9W AAE K Y P K Q L I M DVK T L T 300
agg tactgttcctttatatcccattgcccatgttctggRctcttttggatcagcagggc 973
tcacgatggactttgcaaqccactaagatgaat ggaacttgggatttttt4tgcttcag 1033S R W T L Q A T K M N N L F F L Q 340
ccgqaccagatgcag tactaaaccctctcctggttcttatcttcatcccattatttgac 1093P D Q M Q V L N P L L V L I F I P L F D 360
cttqtcatttatcgtctgatctccaagtgtqgaattaacttcacatcacttagaaaaatg 1153
L V I Y R L I S K C GI N F T S L R K M 380
ct4ttggtatg4t tcta catgcctggcattttqcagctgcaRcaact4ta§aaataaaa 1213fi v a M v L A C L A F A A A A T V E I K 400
ataaatQaaatg ccccaccccagccaqgatcccaaqagattctcctacaaqtCttgaac 1273
I N E M A P P Q P G S Q E I L L Q V L N 420
ctgcagatgataag4tgaagctgaca4tgctgggaaacaataataactctctattg ca 1333L gR K L T L N N 4 N S L Ltg 440
aattccatcaaatcctttcagaaaacacctcactattccaaaatacacctgaatacaaaa 1393
S I K S F Q K T P H Y S K I H L N T K 460
agccaa atttctacttccacctgaaatatcacaatttgtctatatacact aacattct 1453
S Q I F Y F H L K Y H N L S I Y T 5H S 480
qtaqagqagagaaactggtacagtctgatcatccgagaggatqgggaaaagtatctCcagc 1513R N WY SLI I RED K SI 5 5 500
ataatgqtaaagqatatgqaaaatqaaacaacctatqggatgacagctataaggtttatt 1573
I M V K DME N ET T Y GM T AI RF I 520
aacactttgcaa aaaat tcaacatctccctgggtacagatatctccctcaat4ttqgt 1633N T L Q N V I S L G T D I S L N G 540
aaaactacGgggtgstXctcacagaactVtgcaaagaggaEaataccct ca4tacat 1693
tgtaaaaca aagataaagacttttctttgaatctgggtctgctagactttggt cctcg 1753C K T E K I5F S L N L L L F a S 580
tacctgtttqttataactaatagcaccaagcag gacttcag cctggaagatgqaagac 1813Y L F V I T If S T K Q L Q W K M E 600
attcca ccaacaaa4tttccatt catggcaactgccacagtat cctg taaca ct 1873I P A N K VS I A W Q L P O Y g L V T A 620
qgggagqtcatgttctct4tcacaagacttqaattttcttattcacaggctccctctagc 1933
____E ___MFS_ _ T_ _ L EF S Y S Q_A P S S 640
atgaaatct4tactccaggcagcgtggctgttgacaqttqcaattgggaacatcatcqtg 1993M K S V L O0 W L L T V A I GN- I I St 660
ctt tt4tgRcacagittcagtggtctg4tacagtgg ct aatttttttgttttcctgc 2053L V Q S L Q W A E F L F S C 680
ctcctcctggtggtctgcctgatcttctccatcatgqgctactactatattcccataaag 2113
L L L V V C L I F S IM Y Y Y I P I K 700
tca aagatattcaggggcca aagataagcagatcccccatatgcaaaggaacatgatc 2173S ED I Q G K Q I P H M Q N M I 720
aactta§agaccaagaagacaaagctctgatgactcccaggactctgccctgaccccagt 2233
tctcgaccccggtctcaaccatcaccagtctccaagcatatttttctgctattggattag 2293
gcaagaaacatagcatcatttctgagctgatctttcatgtttcttctatgatagaggtat 2353
ttccaggactagattttccagtacaaatttatacaagcaggggattctgtttgttcatct 2413
attagagaactcagtaaaccttgtgaagtgttgctggagttggcctgctgtctccatatg 2473
gccattaaaatgcaaatgtataatggagctcaacctctgcaggtatgtgaagttatgggt 2533
gattcctttacaggcgcctgcattgagaactgaccctgctgttggaggtactgatttaga 2593
ggcaaaattgcagagtaatggagaagcagtatttcagtttctttttttttatctaatttc 2653
tttataagctatttaattgtgctatgcataaagacctcaaaatggtatgtatggcatgat 2713
ctggtctagaggccaacctatcagccatccaagtttgataagaccttagatggtaggagt 2773
taacagaatgacattttattaagccagaggaaatgatatatatttgtgactatgacagta 2833
tcgtatctactcctccaaacactcatttctcagtgccgatagatcctggaaaccagctga 2893
aagatcgcaaacatagttcagtggaacagggacagataaaattgtagaaatcctgataaa 2953
ccattcattctcctgtagtgcacattcctctgaggaactcctttgtttcaaccctgtact 3013
gggtctttctgtggacagctgtatacactagctgtaattttgcaaccttgccctttcact 3073
atagcttgtcagctttttcttattgtatatttctcttgcttatggcagcaaatctttaaa 3133
aacttgtttgcctaagtccaacttcctttttaaattattccatttaacctcaaagtagag 3193
gtttcatttagataaaatttccttgtttaatttccccataattttaaaatgccatttctt 3253
ccttagtcttggaaattccctgtttattttaaaaaggttatattgtagatgttgaggcac 3313
agtgagttaagctgcctcttaggatgcctgcatcccttattggagtgccagtttgagtct 3373
ggctcctccacttcccatccagcttcctgttaatgtgcctggtgaagcagcaaataacag 3433
cccaaatacttggtcccctgctacccacatgggagatctggttggaattcctggctcctg 3493
actttggcctggccctgccctatctattgcagccatttggggagtgaaccagaagataaa 3553
agatttttctctaactctccttctctctctgtcactttgtcttccaagtaaataataatc 3613
tttttaaaggttaatgttcaattttcaggttctaaaatagtgatactctgcaagagggca 3673
tgatcttgaatgagaaatcctgtcaaaatctgtgtttgtgggtgtggcagggggagggga 3733
aggtagagcatgagggctttttatttgtgtatgtggtcatgaagaaaagttgaaaaacat 3793
tgccttgcacaaaatgaatgaatcggaagacagacttcgggcatatcatcgactgtgcag 3853
agagttgctggggggaagagttctgtaccaccgtagacagtcttacttctcgttgatttt 3913
actccgttctcatctaggacagtgttgggtctcacattgttaatataacaagagaattgg 3973
ctcttgctccccagcctttgtacactttagctttaatcaccaacgtgtcagaagttcaga 4033
gatggcagaaacacccaagtttccccagacatcttcatgtgaaccagaccctacttcttt 4093
agaacaaagcctgtttacttttaagcagatctaacccaagctgttctatgaatattgttt 4153
tcaagatttgttaacactgttctgcaaataaactatctatgggcaaataagtttggaaaa 4213
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa 4265
FIG. 8. Nucleotide sequence and predicted amino acid sequence of rPepT2. Nucleotide sequence (upper row) and deduced amino acid sequence
(lower row) of rPepT2. The numbers on the right refer to the nucleotide and amino acid positions and the underlined areas indicate the putative
transmembrane domains. Potential extracellular N-glycosylation sites are indicated by asterisks, and potential protein kinase C phosphorylation
sites on the cytoplasmic surface are labeled by filled circles.
irradiation with high-energy electrons (23) suggesting label-
ing of a specific proton-dependent membrane protein. We
therefore speculate that the photolabeled 105-kDa mem-
brane protein most likely represents the gene product of
rPepT2 or a related protein with similar if not identical
functions. In addition, target size analysis of the high-affinity
peptide transport system in BBMV assessed by radiation
inactivation of high-affinity [3H]cefadroxil uptake activity
(23) suggested an apparent functional molecular mass of the
transport protein of 414 ± 16 kDa that could represent the
rPepT2 gene product functioning in an oligomeric arrange-
ment, for example as a homotetramer.
In conclusion, we have cloned a cDNA from a rabbit kidney
cortex cDNA library that codes for a 729-amino acid protein
with an apparent monomer molecular mass of 107 kDa (core
glycosylated form) and 12 membrane-spanning domains. It
shows significant homology to other members of the POT
family of proton-dependent oligopeptide transporters. The
functional characteristics of the gene product determined in
Xenopus oocytes are very similar to, if not identical with, the
peptide transport activity found in the apical membrane
vesicles of kidney tubular cells. Peptide transport mediated by
rPepT2 is of the high-affinity type, occurs by electrogenic
substrate/H+ symport, and is strongly affected by membrane
potential. The presence of the transporter in kidney tubular
cells may significantly contribute to the conservation of amino
acids by enabeling high-affinity reabsorption of a large variety
of di- and tripeptides occurring in the tubular fluid.
Note Added in Proof. During the reviewing of this manuscript, a report
describing the cloning of a peptide transporter from human kidney was
published (24). PepT2 from human kidney has significant homology to
rPepT2 described in the present paper.
This work was supported by Deutsche Forschungsgemeinschaft
Grant SFB 249/B12.
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